SB-431542 is a novel small molecule inhibitor of the type I TGF-beta receptor, on a panel of human malignant glioma cell lines. SB-431542 blocked the phosphorylation and nuclear translocation of the SMADs, intracellular mediators of TGF-beta signaling, with decreased TGF-beta-mediated transcription. Furthermore, SB-431542 inhibited the expression of two critical effectors of TGF-beta-vascular endothelial growth factor and plasminogen activator inhibitor-1.
Tags: buy SB-431542 | purchase SB-431542 | SB-431542 cost | order SB-431542 | SB-431542 chemical structure | SB-431542 in vivo | SB-431542 in vitro | SB-431542 formula | SB-431542 molecular weight